Inactive Instrument

Highlights Roche Holding Ltd. Swiss Exchange

Equities

End-of-day quote Swiss Exchange Other stock markets
- ^CHF	-

05-10	Xbrane Biopharma, Stada Sign US Licensing Deal for Lucentis Biosimilar	MT
05-07	Enable Injections, Inc. Announces Collaboration with Roche to Develop and Commercialize Combination of the enFuse Technology with Specific Roche Development Programs	CI

Xbrane Biopharma, Stada Sign US Licensing Deal for Lucentis Biosimilar	05-10	MT
Enable Injections, Inc. Announces Collaboration with Roche to Develop and Commercialize Combination of the enFuse Technology with Specific Roche Development Programs	05-07	CI
Swiss Equities Close in Red Amid Inflation Spotlight	04-29	MT
Roche Holding AG: slimming down	04-29
European Medicines Agency Committee Backs Roche's Subcutaneous Injection for Multiple Sclerosis	04-29	MT
Roche’s Lung Cancer Drug Alecensa Backed for Approval in EU	04-26	MT
The specter of stagflation rears its ugly head again	04-25
ROCHE : Barclays lowers target price	04-25	CF
Scholz pledges further support for the pharmaceutical industry	04-25	DP
Scholz promises support for pharma sector in Germany as Merck invests	04-25	RE
Chugai Pharmaceutical's Parent Roche Logs Lower Q1 Sales; Stock Falls 5%	04-25	MT
Roche’s Downbeat Q1 Sales Drag Swiss Market Index to Red	04-24	MT
ROCHE HOLDING : In line quarterly results won’t cut it for Roche	04-24
Global markets live: Heineken, AT&T Hasbro, Visa, Boeing...	04-24
Biogen beats quarterly profit estimates, Alzheimer's drug sales jump	04-24	RE
Roche Eyes Potential M&A Deals Amid Pipeline Restructure	04-24	MT
Shares jump on tech boost; fragile yen on intervention watch	04-24	RE
Roche Sees Return to Growth Ahead After Forex, Post-pandemic Slump Hit First-quarter Sales	04-24	MT
European shares flat, with focus on mixed bag of earnings	04-24	RE
Correction to Roche Article	04-24	DJ

No results for this search

ROCHE HOLDING : In line quarterly results won’t cut it for Roche

April 24, 2024 at 11:50 am

Obesity: Roche joins the battle

December 04, 2023 at 10:48 am